Inter-individual differences in pain anticipation and pain perception in migraine: Neural correlates of migraine frequency and cortisol-to-dehydroepiandrosterone sulfate (DHEA-S) ratio

PLoS One. 2021 Dec 20;16(12):e0261570. doi: 10.1371/journal.pone.0261570. eCollection 2021.

Abstract

Previous studies targeting inter-individual differences in pain processing in migraine mainly focused on the perception of pain. Our main aim was to disentangle pain anticipation and perception using a classical fear conditioning task, and investigate how migraine frequency and pre-scan cortisol-to-dehydroepiandrosterone sulfate (DHEA-S) ratio as an index of neurobiological stress response would relate to neural activation in these two phases. Functional Magnetic Resonance Imaging (fMRI) data of 23 participants (18 females; mean age: 27.61± 5.36) with episodic migraine without aura were analysed. We found that migraine frequency was significantly associated with pain anticipation in brain regions comprising the midcingulate and caudate, whereas pre-scan cortisol-to DHEA-S ratio was related to pain perception in the pre-supplementary motor area (pre-SMA). Both results suggest exaggerated preparatory responses to pain or more general to stressors, which may contribute to the allostatic load caused by stressors and migraine attacks on the brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Brain Chemistry
  • Dehydroepiandrosterone Sulfate / analysis
  • Dehydroepiandrosterone Sulfate / metabolism*
  • Female
  • Functional Neuroimaging
  • Humans
  • Hydrocortisone / analysis
  • Hydrocortisone / metabolism*
  • Individuality
  • Magnetic Resonance Imaging
  • Male
  • Migraine Disorders / epidemiology
  • Migraine Disorders / psychology*
  • Pain Perception*
  • Young Adult

Substances

  • Dehydroepiandrosterone Sulfate
  • Hydrocortisone

Grants and funding

The study was supported by the MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group, Hungarian Academy of Sciences, Semmelweis University (Grant No. KTIA_NAP_13-2-2015-0001) to GJ; Hungarian Brain Research Programe (Grant No. 2017-1.2.1-NKP-2017-00002) to GJ and the Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group) To GB. The preparation of this work was supported by the Thematic Excellence Programme (Tématerületi Kiválósági Program, 2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Neurology and Translational Biotechnology thematic programmes of the Semmelweis University. LRK was supported by the Bolyai Research Fellowship Program of the Hungarian Academy of Sciences. The preparation of this article for GK was supported by the Hungarian National Research, Development and Innovation Office (FK128614). GJ was supported by the Hungarian National Research, Development and Innovation Office, Hungary (2019-2.1.7-ERA-NET-2020-00005), under the frame of ERA PerMed (ERAPERMED2019-108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.